A high dose of Wegovy that helped people lose 21% of their weight in a clinical trial was just approved March 19, 2026 MMN Editor Filed Under: MarketWatch, SUCCESSNovo Nordisk’s 7.2 mg dose of Wegovy will compete against Lilly’s GLP-1 injection.